申请人:American Home Products Corporation
公开号:US20020035099A1
公开(公告)日:2002-03-21
This invention relates to cyclic combination therapies and regimens utilizing substituted indoline derivative compounds that are antagonists of the progesterone receptor having the general structure:
1
wherein: R
1
, and R
2
are chosen independently from each other from H, OH; OAc; alkylaryl; alkylheteroaryl; 1-propynyl; 3-propynyl; and optionally substituted alkyl, O(alkyl); aryl; or heteroaryl groups; or R
1
and R
2
are joined to form a ring comprising —CH
2
(CH
2
)
n
CH
2
— where n=0-5; —CH
2
CH
2
CMe
2
CH
2
CH
2
—; —O(CH
2
)
m
CH
2
— where m=1-4; O(CH
2
)
p
O— where p=1-4; —CH
2
CH
2
OCH
2
CH
2
—; —CH
2
CH
2
N(H or alkyl)CH
2
CH
2
—;
or R
1
and R
2
together comprise a double bond to CMe
2
; C(cycloalkyl), O, or C(cycloether);
R
3
is H, OH, NH
2
, COR
A
; or optionally substituted alkenyl or alkynyl groups;
R
A
=H or optionally substituted alkyl, alkoxy, or aminoalkyl groups;
R
4
=H, halo, CN, NH
2
, or optionally substituted alkyl, alkoxy, or aminoalkyl;
R
5
is selected from optionally substituted benzene ring; a five or six membered heterocyclic ring; a 4 or 7-substituted indole or a substituted benzothiophene; or pharmaceutically acceptable salt thereof. These methods of treatment may be used for contraception or for the treatment and/or prevention of secondary amenorrhea, dysfunctional bleeding, uterine leiomyomata, endometriosis; polycystic ovary syndrome, carcinomas and adenocarcinomas of the endometrium, ovary, breast, colon, prostate, or mininization of side effects or cyclic menstrual bleeding. Additional uses of the invention include stimulation of food intake.
本发明涉及使用取代的吲哚啉衍生物化合物的循环组合疗法和方案,它们是孕激素受体拮抗剂,具有以下一般结构:1其中:R1和R2分别选择自H、OH、OAc、烷基芳基、烷基杂芳基、1-丙炔基、3-丙炔基和可选取代烷基、O(烷基)、芳基或杂芳基基团;或R1和R2结合形成包含—CH2(CH2)nCH2—的环,其中n=0-5;—CH2CH2CMe2CH2CH2—;—O(CH2)mCH2—其中m=1-4;O(CH2)pO—其中p=1-4;—CH2CH2OCH2CH2—;—CH2CH2N(H或烷基)CH2CH2—;或R1和R2一起包括双键到CMe2;C(环烷基)、O或C(环乙醚);R3为H、OH、NH2、CORA或可选取代的烯烃或炔烃基团;RA=H或可选取代的烷基、烷氧基或氨基烷基基团;R4=H、卤素、CN、NH2或可选取代的烷基、烷氧基或氨基烷基;R5选自可选取代的苯环、五元或六元杂环、4或7-取代吲哚或取代苯并噻吩;或其药学上可接受的盐。这些治疗方法可用于避孕或用于治疗和/或预防继发性闭经、功能性出血、子宫平滑肌瘤、子宫内膜异位症、多囊卵巢综合症、子宫内膜、卵巢、乳腺、结肠、前列腺的癌瘤和腺癌,或减少副作用或循环月经出血。本发明的其他用途包括促进食物摄入。